HYPERION THERAPEUTICS INC

Profile

Company Names

HYPERION THERAPEUTICS INC

Addresses

2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE, CA 94005

601 GATEWAY BLVD., SUITE 200, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

(650) 745-7802
645-745-7802

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2006

State Incorporated:

DE

Total Amount Raised:

$67,934,046.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2014-06-12 
$7,990,674.00 
$7,990,674.00 
$0.00 
Equity 
4
2011-10-26 
$7,500,749.00 
$15,030,000.00 
$7,529,251.00 
Equity, Debt 
3
2011-04-01 
$17,471,998.00 
$35,000,000.00 
$17,528,002.00 
Equity, Debt 
2
2009-06-29 
$21,981,863.00 
$45,461,554.00 
$23,479,691.00 
Equity 
1
2008-08-05 
$12,988,762.00 
$15,000,000.00 
$2,011,238.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GAURAV 
 
AGGARWAL 
DIRECTOR
HYPERION THERAPEUTICS INC   |  NEXTWAVE PHARMACEUTICALS INC   |  AUSPEX PHARMACEUTICALS, INC.   |  VIVO OPPORTUNITY FUND, L.P.   |  VIVO OPPORTUNITY CO-INVEST, L.P.   |  VIVO OPPORTUNITY CO-INVEST (W), L.P.   |  UNICYCIVE THERAPEUTICS, INC.   |  VIVO OPPORTUNITY CAYMAN FUND, L.P.   |  VIVO CAPITAL FUND X, L.P.   |  BONUM THERAPEUTICS, INC.
DION 
 
COAKLEY 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC
KLARA 
 
DICKINSON 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC
KLARA 
A. 
DICKINSON 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC
JEFFREY 
 
FARROW 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC
JEFFREY 
S. 
FARROW 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC
ASHLEY 
 
GOULD 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC   |  PAX LABS, INC.   |  JUUL LABS, INC.
DAVID 
 
GRYSKA 
DIRECTOR
HYPERION THERAPEUTICS INC   |  ARGOS THERAPEUTICS INC   |  AERIE PHARMACEUTICALS INC   |  FORTE BIOSCIENCES, INC.   |  MIND MEDICINE (MINDMED) INC.
BO 
JESPER 
HANSEN 
DIRECTOR
GENSPERA INC   |  HYPERION THERAPEUTICS INC   |  INSPYR THERAPEUTICS, INC.
BO JESPER 
 
HANSEN 
DIRECTOR
HYPERION THERAPEUTICS INC
JAMES 
 
HEALY 
DIRECTOR
GFP MANAGED EQUITIES I LP   |  DXTERITY DIAGNOSTICS INC   |  SORBENT THERAPEUTICS INC   |  HYPERION THERAPEUTICS INC   |  DFMSIM INC   |  SOFINNOVA VENTURE PARTNERS VIII, L.P.   |  KALOBIOS PHARMACEUTICALS INC   |  GRAN PARADISO CAPITAL PARTNERS, LLC   |  ASCENDIS PHARMA A/S   |  CAPRA IBEX CLO INVESTOR, LLC   |  BOLT BIOTHERAPEUTICS, INC.   |  SOFINNOVA SYNERGY MASTER FUND, LP   |  ARRIVENT BIOPHARMA, INC.   |  ATSENA THERAPEUTICS, INC.   |  BIOAGE LABS, INC.
JAMES 
I. 
HEALY 
DIRECTOR
CEBIX INCOPRATED   |  AMARIN CORP PLC\UK   |  SORBENT THERAPEUTICS INC   |  CEBIX INC   |  HYPERION THERAPEUTICS INC   |  ITERUM THERAPEUTICS LTD   |  SOFINNOVA VENTURE PARTNERS X, L.P.   |  ITERUM THERAPEUTICS BERMUDA LTD   |  ITERUM THERAPEUTICS PLC   |  ITERUM THERAPEUTICS US LTD   |  ITERUM THERAPEUTICS US HOLDING LTD   |  ITERUM THERAPEUTICS INTERNATIONAL LTD   |  SEAPORT THERAPEUTICS, INC.
JIM 
 
HEALY 
DIRECTOR
HYPERION THERAPEUTICS INC
NATALIE 
 
HOLLES 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC   |  DAY ONE BIOPHARMACEUTICALS HOLDING CO LLC   |  RENASANT BIO, INC.
ROB 
 
HOPFNER 
DIRECTOR
HYPERION THERAPEUTICS INC   |  ALTHEOS, INC.   |  CIVITAS THERAPEUTICS, INC.   |  SUTROVAX, INC.   |  INOZYME PHARMA, INC.   |  RALLYBIO CORP   |  LAND MEDICINE INC.   |  PLEXIUM, INC.
ROBERT 
 
HOPFNER 
DIRECTOR
HYPERION THERAPEUTICS INC   |  CIVITAS THERAPEUTICS, INC.   |  IMARA INC.   |  ITERUM THERAPEUTICS LTD   |  RALLYBIO HOLDINGS, LLC   |  EVOMMUNE, INC.
TONI 
 
MARTINEZ 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC
MASOUD 
 
MOKHTARANI 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC
CHRISTINE 
 
NASH 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC
CHRISTINE 
A. 
NASH 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC   |  RALLYBIO CORP
JAKE 
 
NUNN 
DIRECTOR
HYPERION THERAPEUTICS INC   |  TV2 HOLDING CO   |  ACIEX THERAPEUTICS, INC.   |  DERMIRA, INC.   |  TRIVASCULAR TECHNOLOGIES, INC.   |  ADDEX THERAPEUTICS LTD.   |  ZENAS BIOPHARMA, INC.
JAKE 
R. 
NUNN 
DIRECTOR
HYPERION THERAPEUTICS INC   |  DERMIRA, INC.   |  TRIVASCULAR TECHNOLOGIES, INC.   |  REGULUS THERAPEUTICS INC.
DANIEL 
 
PEREZ 
DIRECTOR
CLEVELAND BIOLABS INC   |  HYPERION THERAPEUTICS INC   |  PRESIDIO PHARMACEUTICALS, INC.   |  ACCELERATED PHARMA, INC.   |  HINGE HEALTH, INC.
BIJAN 
 
SALEHIZADEH 
DIRECTOR
HYPERION THERAPEUTICS INC   |  OPGEN INC   |  PREDICTIVE BIOSCIENCES, INC   |  NAVIMED PARTNERS EXECUTIVE FUND, L.P.   |  NAVIMED PARTNERS, L.P.   |  AURIS SURGICAL ROBOTICS, INC.   |  AURIS HEALTH, INC.   |  VCR HOLDINGS, LLC   |  LUMERE, INC.   |  NAVIMED PARTNERS II, L.P.   |  NM-ASWC HOLDINGS, LLC   |  ALEDADE, INC.
DON 
 
SANTEL 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC
DONALD 
 
SANTEL 
EXECUTIVE OFFICER, DIRECTOR
HYPERION THERAPEUTICS INC   |  ABILITECH MEDICAL, INC.   |  ADICET BIO, INC.   |  OCELOT BIO, INC.
DONALD 
J. 
SANTEL 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC   |  TENTARIX BIOTHERAPEUTICS, LP
BRUCE 
 
SCHARSCHMIDT 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC
BRUCE 
F. 
SCHARSCHMIDT 
EXECUTIVE OFFICER
HYPERION THERAPEUTICS INC
DANIEL 
G. 
WELCH 
DIRECTOR
SEATTLE GENETICS INC /WA   |  HYPERION THERAPEUTICS INC
LOTA 
 
ZOTH 
DIRECTOR
HYPERION THERAPEUTICS INC
LOTA 
S. 
ZOTH 
DIRECTOR
IKARIA HOLDINGS INC   |  HYPERION THERAPEUTICS INC   |  INOVIO PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-06-18
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
Equity 
2014-06-12 
2011-11-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-10-26 
2011-04-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-04-01 
2009-07-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-29 
2009-05-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2008-08-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#